Baird analyst Michael Halloran raised the firm’s price target on Xylem to $170 from $155 and keeps an Outperform rating on the shares. The firm said they posted a solid Q2 with its outlook unchanged. The firm moved its estimates higher and said Xylem remains a Top Idea.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL: